1 / 44

The Good, Bad, Ugly and Deadly

The Good, Bad, Ugly and Deadly. Two Types of Lipids. Composition of Lipoprotein. TG. EC. Apoprotein boat. classification based on the relative densities of the aggregates on ultracentrifugation. Lipoproteins. Apo A I and A II for HDL Apo B100 for LDL

hume
Télécharger la présentation

The Good, Bad, Ugly and Deadly

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. www.drsarma.in

  2. The Good, Bad, Ugly and Deadly

  3. Two Types of Lipids

  4. Composition of Lipoprotein

  5. TG EC Apoprotein boat classificationbased on the relative densities of the aggregates on ultracentrifugation Lipoproteins Apo A I and A II for HDLApo B100 for LDL Apo B100+C+E for VLDL, IDLApo B100+Apo(a) for Lp(a)

  6. HDL A I, A II B 100 B 100+ (a) TG C C TG TG TG C C B 100 + E +C Good, Bad, Ugly & Deadly LDL GOOD BAD VLDL Lp(a) UGLY DEADLY TG

  7. Apolipoprotein B Measurements Non-HDL-C VLDL VLDLR IDL LDL SDL TG-rich lipoproteins All are the terrorists !! Highly atherogenic

  8. Lipid Profile Report PP Fasting

  9. Normal Lipid Profile • Total Cholesterol < 200 • TG ‘Ugly’ Lipid < 150 • ‘Bad’ Cholesterols LDL < 100 • HDL ‘Good’ cholesterol > 50 • VLDL is Ugly TG ÷ 5 < 30 • Lp(a) ‘Deadly’ cholesterol < 20

  10. Normal range

  11. Cholesterol

  12. Specimen • Serum, Plasma (EDTA, Heparin) • Certain anticoagulants, such as fluoride, citrate, and oxalate, cause large shifts of water from the red blood cells to the plasma, which result in the dilution of plasma components. • Storage and Stability • 7 days at 20 – 25 °C • 7 days at 4 – 8 °C • 3 months at -20 °C

  13. Principle: Enzymatic Reaction • Determination of cholesterol after enzymatic hydrolysis and oxidation. • The colorimetric indicator is quinoneimine which is generated from 4-aminoantipyrine and hydroxybenzoate by hydrogen peroxide under the catalytic action of peroxidase Cholesterol Esterase Cholesterol oxidase Peroxidase

  14. Linearity • Dilution • Source of errors

  15. Triglycerides

  16. Specimen • Serum • Plasma (EDTA) or heparin • Certain anticoagulants, such as fluoride, citrate, and oxalate, cause large shifts of water from the red blood cells to the plasma, which result in the dilution of plasma components. • Fasting sample (from 12 to 16 h) is essential for triglyceride analysis • Storage and stability

  17. Principle: Enzymatic Method Lipoprotein lipase • Triglycerides Glycerol + 3 fatty acids • Glycerol + ATP Glycerol-3 phosphate + ADP • Glycerol-3 phosphate dihydroxyacetone + H2O2phosphate • H2O2 + 4-aminophenazone+ESPA Quinoneimine glycerolkinase glycerolphosphate oxidase peroxidase

  18. Linearity • Dilution • Source of errors

  19. Triglycerides NCEP 2004 Guidelines by expert panel on TG

  20. HDL • HDL is a fraction of plasma lipoproteins • It is composed of 50% protein, 25% phospholipid, 20% cholesterol, and 5% triglycerides • Evidence suggests that high-density lipoprotein (HDL) cholesterol is cardioprotective. • LDL-chol = [Total chol] - [HDL-chol] - ([TG]/2.2) where all concentrations are given in mmol/L • (note that if calculated using all concentrations in mg/dL then the equation is [LDL-chol] = [Total chol] - [HDL-chol] - ([TG]/5))

  21. Limitations of the Friedewald equation • The Friedewald equation should not be used under the following circumstances: • when chylomicrons are present. • when plasma triglyceride concentration exceeds 400 mg/dL (4.52 mmol/L). • in patients with type III hyperlipoproteinemia.

  22. TC, TGs, and HDL cholesterol are measured directly; TC and TG values reflect cholesterol and TGs in all circulating lipoproteins, including chylomicrons, VLDL, intermediate-density lipoprotein (IDL), LDL, and HDL. TC values vary by 10% and TGs by up to 25% day-to-day even in the absence of a disorder. TC and HDL cholesterol can be measured in the nonfasting state, but most patients should have all lipids measured while fasting for maximum accuracy and consistency. • Patients with an extensive family history of heart disease should also be screened by measuring Lp(a) levels.

  23. Testing should be postponed until after resolution of acute illness, because TGs increase and cholesterol levels decrease in inflammatory states. Lipid profiles can vary for about 30 days after an acute MI; however, results obtained within 24 h after MI are usually reliable enough to guide initial lipid-lowering therapy.

  24. LDL cholesterol values are most often calculated as the amount of cholesterol not contained in HDL and VLDL. VLDL is estimated by TG ÷ 5 because the cholesterol concentration in VLDL particles is usually 1/5 of the total lipid in the particle. Thus, LDL cholesterol = TC − [HDL cholesterol + (TGs ÷ 5)] (Friedewald formula). This calculation is valid only when TGs are < 400 mg/dL and patients are fasting, because eating increases TGs. The calculated LDL cholesterol value incorporates measures of all non-HDL, nonchylomicron cholesterol, including that in IDL and lipoprotein (a) [Lp(a)]..

  25. LDL can also be measured directly using plasma ultracentrifugation, which separates chylomicrons and VLDL fractions from HDL and LDL, and by an immunoassay method. Direct measurement may be useful in some patients with elevated TGs, but these direct measurements are not routinely necessary. The role of apo B testing is under study because values reflect all non-HDL cholesterol (in VLDL, VLDL remnants, IDL, and LDL) and may be more predictive of CAD risk than LDL alone.

  26. Discussion Interpretation of Results

  27. How to interpret Lipid Profile Report? 200 • Total Cholesterol HDL Cholesterol (Soldiers) - Good Non HDL Cholesterol(Culprits) LDL Cholesterol – Bad fellows Lipoprotein(a) – Deadly fellows VLDL Cholesterol (1/5 of TG)- Ugly B. Triglycerides 50 150 100 20 30 150 Normal Lipid Profile

  28. Interpret this Lipid Profile Report 240 • Total Cholesterol HDL Cholesterol (Soldiers) - Good Non HDL Cholesterol(Culprits) LDL Cholesterol – Bad fellows Lipoprotein(a) – Deadly fellows VLDL Cholesterol (1/5 of TG)- Ugly B. Triglycerides 50 190 140 20 30 150 Hyper cholesterolimia ↑LDL, HDL, TG, Lp(a) - N

  29. Interpret this Lipid Profile Report 200 • Total Cholesterol HDL Cholesterol (Soldiers) - Good Non HDL Cholesterol(Culprits) LDL Cholesterol – Bad fellows Lipoprotein(a) – Deadly fellows VLDL Cholesterol (1/5 of TG)- Ugly B. Triglycerides 50 150 70 20 60 300 Hyper triglyceridemia ↑TG, HDL, LDL, Lp(a) - N

  30. Interpret this Lipid Profile Report 160 • Total Cholesterol HDL Cholesterol (Soldiers) - Good Non HDL Cholesterol(Culprits) LDL Cholesterol – Bad fellows Lipoprotein(a) – Deadly fellows VLDL Cholesterol (1/5 of TG)- Ugly B. Triglycerides 25 135 85 20 30 150 Low HDL : ↓HDL, LDL, TG, Lp(a) - N

  31. Interpret this Lipid Profile Report 200 • Total Cholesterol HDL Cholesterol (Soldiers) - Good Non HDL Cholesterol(Culprits) LDL Cholesterol – Bad fellows Lipoprotein(a) – Deadly fellows VLDL Cholesterol (1/5 of TG)- Ugly B. Triglycerides 45 155 75 50 30 150 High Lipoprotein(a) : ↑Lp(a), HDL, LDL, TG - N

  32. Interpret this Lipid Profile Report 200 • Total Cholesterol HDL Cholesterol (Soldiers) - Good Non HDL Cholesterol(Culprits) LDL Cholesterol – Bad fellows Lipoprotein(a) – Deadly fellows VLDL Cholesterol (1/5 of TG)- Ugly B. Triglycerides 25 175 95 20 60 300 High Lipoprotein(a) : ↓HDL, ↑TG, LDL, Lp(a) - N

  33. Interpret this Lipid Profile Report 260 • Total Cholesterol HDL Cholesterol (Soldiers) - Good Non HDL Cholesterol(Culprits) LDL Cholesterol – Bad fellows Lipoprotein(a) – Deadly fellows VLDL Cholesterol (1/5 of TG)- Ugly B. Triglycerides 50 210 120 40 50 250 Combined Dyslipidemia : ↑ TC↑LDL↑TG ↑Lp(a)

  34. Look at the risks • Low HDL + High LDL + • LP(a) excess > 30 mg% + • LP(a) excess > 30 mg% + LDL high ++ • LP(a) excess > 30 mg% + low HDL +++ • LP(a) excess > 30 mg% + Incr. tHCy ++++ • LP(a) excess + Incr. tHCy + low HDL +++++ • Circulating lipids are one aspects • Tissue lipid content is more important J. Atherosclerosis : Hopkins PN, 1997 – 17, 2792

  35. Dyslipidemia • is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein level that contributes to the development of atherosclerosis. Causes may be primary (genetic) or secondary. Diagnosis is by measuring plasma levels of total cholesterol, TGs, and individual lipoproteins. Treatment is dietary changes, exercise, and lipid-lowering drugs.

  36. Case Study #1 • 47 year-old man who is overweight (BMI 29) and who reports he frequently eats out, often at fast food places. • What assessment tests would you recommend?

  37. He is noted to have a blood pressure of 144/86 mmHg (average of two tests) and a fasting blood sugar of 115 mg/dl • His lipid profile shows an LDL-C of 162 mg/dl and an HDL-C of 36 mg/dl, with a triglycerides of 175 mg/dl. • What should the approach to treatment be and goals proposed?

  38. Case Study #2 • A 28-year old female has been diagnosed by a physician with diabetes. • What assessment tests would you order?

  39. A blood pressure of 134/82 mmHg is noted (mean of two measures) • A fasting lipid profile shows an HDL-C of 40 mg/dl and LDL-C of 140 mg/dl is noted, with triglycerides of 260 mg/dl. • What should the approach to treatment be?

  40. Case Study #3 • A 64-year old woman is admitted to the hospital and diagnosed with a myocardial infarction. She reports a history and has been on treatment for hypertension with. • What assessments should be performed?

  41. A fasting lipid profile done 12 hours after admission shows an LDL-C of 125 mg/dl, HDL-C of 30 mg/dl, and triglycerides of 150 mg/dl • Any other recommendations for treatment?

  42. Clinical Action • For all above 20 years once in every 5 years • For those above 45 yrs – once in 2 years • For those with already known lipid abnormality follow-up every 3-6 months • Extended Lipid profile includes Homocysteine, LP(a), SD-LDL, ALP, Apo A and Apo B, hS-CRP

  43. There is no natural cutoff between normal and abnormal lipid levels because lipid measurements are continuous • A linear relation probably exists between lipid levels and cardiovascular risk • elevated TG and low HDL levels are more predictive of cardiovascular risk in women than in men • HDL levels do not always predict cardiovascular risk. High HDL levels caused by some genetic disorders may not protect against cardiovascular disorders, and low HDL levels caused by some genetic disorders may not increase the risk of cardiovascular disorders.

  44. Proof of treatment benefit is strongest for lowering elevated low-density lipoprotein (LDL) levels. In the overall population, evidence is less strong for a benefit from lowering elevated TG and increasing low high-density lipoprotein (HDL) levels, in part because elevated TG and low HDL levels are more predictive of cardiovascular risk in women than in men

More Related